Acute sensory ataxic neuropathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:231466G61.0
Who is this for?
Show terms as
5Active trials8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Acute sensory ataxic neuropathy (ASAN) is a rare acquired peripheral neuropathy characterized by the rapid onset of sensory ataxia — a loss of coordination caused by impaired proprioception (the body's sense of position and movement) rather than cerebellar dysfunction. It is classified within the spectrum of acute inflammatory demyelinating or axonal neuropathies and shares features with Guillain-Barré syndrome (GBS), specifically resembling an acute sensory variant. The condition predominantly affects the peripheral nervous system, targeting large-diameter sensory nerve fibers responsible for proprioception and vibration sense. Patients typically present with an acute or subacute onset of unsteadiness, difficulty walking (sensory ataxia), numbness, tingling, and loss of deep tendon reflexes (areflexia). Limb weakness is absent or minimal, distinguishing ASAN from classic motor-predominant forms of GBS. Patients may have difficulty with fine motor tasks due to impaired sensory feedback. Nerve conduction studies typically show abnormalities in sensory nerve action potentials, while motor conduction may be relatively preserved. The condition is thought to have an immune-mediated pathogenesis, and some cases are preceded by an infectious illness. Treatment is largely supportive and based on approaches used for Guillain-Barré syndrome, including intravenous immunoglobulin (IVIg) and plasmapheresis (plasma exchange), although evidence for efficacy in this specific variant is limited and largely based on case reports and small series. Physical rehabilitation focusing on balance and gait training is an important component of management. The prognosis is variable; some patients recover substantially, while others may have persistent sensory deficits and ataxia. Given its rarity, there are no large-scale clinical trials specifically addressing ASAN, and management decisions are often individualized.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

5 events
Sep 2023Asan Aorta and Peripheral Registry

Asan Medical Center

TrialRECRUITING
Apr 2018Asan Medical Center Myocardial Infarction Registry

Seung-Jung Park

TrialRECRUITING
Dec 2017ASAN Medical Center Aortic Valve Replacement Registry

Ho-Jin Kim

TrialACTIVE NOT RECRUITING
Mar 2014Asan Multivessel Registry

Seung-Jung Park

TrialRECRUITING
Jan 2003Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

Seung-Jung Park

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Acute sensory ataxic neuropathy.

5 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

5 recruitingView all trials with filters →
Other5 trials
Asan Medical Center Myocardial Infarction Registry
Actively Recruiting
· Sites: Seoul · Age: 1999 yrs
Asan Multivessel Registry
Actively Recruiting
· Sites: Seoul · Age: 1999 yrs
ASAN Medical Center Aortic Valve Replacement Registry
Active
PI: Seung-jung Park, MD (Asan Medical Center) · Sites: Seoul
Asan Aorta and Peripheral Registry
Actively Recruiting
PI: Seung-Whan Lee (Asan Medical Center) · Sites: Seoul · Age: 1999 yrs
Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)
Actively Recruiting
PI: Seung-Jung Park, MD, PhD (Asan Medical Center) · Sites: Seoul · Age: 1899 yrs

No specialists are currently listed for Acute sensory ataxic neuropathy.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Acute sensory ataxic neuropathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Acute sensory ataxic neuropathyForum →

No community posts yet. Be the first to share your experience with Acute sensory ataxic neuropathy.

Start the conversation →

Latest news about Acute sensory ataxic neuropathy

Disease timeline:

New recruiting trial: Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

A new clinical trial is recruiting patients for Acute sensory ataxic neuropathy

New recruiting trial: Asan Multivessel Registry

A new clinical trial is recruiting patients for Acute sensory ataxic neuropathy

New recruiting trial: Asan Medical Center Myocardial Infarction Registry

A new clinical trial is recruiting patients for Acute sensory ataxic neuropathy

New recruiting trial: Asan Aorta and Peripheral Registry

A new clinical trial is recruiting patients for Acute sensory ataxic neuropathy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Acute sensory ataxic neuropathy

What is Acute sensory ataxic neuropathy?

Acute sensory ataxic neuropathy (ASAN) is a rare acquired peripheral neuropathy characterized by the rapid onset of sensory ataxia — a loss of coordination caused by impaired proprioception (the body's sense of position and movement) rather than cerebellar dysfunction. It is classified within the spectrum of acute inflammatory demyelinating or axonal neuropathies and shares features with Guillain-Barré syndrome (GBS), specifically resembling an acute sensory variant. The condition predominantly affects the peripheral nervous system, targeting large-diameter sensory nerve fibers responsible for

How is Acute sensory ataxic neuropathy inherited?

Acute sensory ataxic neuropathy follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Acute sensory ataxic neuropathy typically begin?

Typical onset of Acute sensory ataxic neuropathy is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Acute sensory ataxic neuropathy?

Yes — 5 recruiting clinical trials are currently listed for Acute sensory ataxic neuropathy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.